Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Elizabeth Ormondroyd comments on recent NHS plans in The Conversation.

Dr Ormondroyd, a genetic counsellor and an RDM researcher, explores the implications of new NHS proposals to offer healthy people a paid service to have their genome sequence, and points out the difficulties in interpreting genome sequencing data for healthy people with no family history of a particular disease. 

Read the full article at The Conversation

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Two NHSBT research units launch at RDM

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford, with two of them led by RDM researchers.

Professor David Roberts elected Fellow of Academy of Medical Sciences

David Roberts, Professor of Haematology at the Radcliffe Department of Medicine and Consultant Haematologist, has been elected a Fellow of the Academy of Medical Sciences

REF 2021 outcomes